MMSI Stock — Merit Medical Systems, Inc.

Merit Medical Systems, Inc. (MMSI)

Updated October 16, 2026.

MMSI is a Stock. Total return is 10082.6% over the past 36.4 years.

Merit Medical Systems designs, manufactures, and markets single-use medical devices for interventional, diagnostic, and therapeutic procedures, operating through Cardiovascular and Endoscopy segments that serve hospitals and physicians globally. The company does not currently have an established distribution program. This operating company appeals to investors seeking exposure to the medical device sector without an expectation of regular dividend income.

MMSI performance

Price and return data through 2026-10-16.

Total return is 10082.6% over the past 36.4 years. Over the past year its total return — price change plus distributions reinvested — is 10.4%. Its deepest 1-year drawdown was 35.3%.

MMSI key facts

Asset type

Stock

Asset class

Equity

Inception date

05/14/1990

Distribution frequency

None

Last close

$89.20 (as of 2026-10-16)

Market cap

$5,326,169,464

Average volume

484425.0

Beta

0.508

Payout ratio

0.0%

P/E ratio

36.71

Forward P/E

18.9394

EPS

$2.43

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

MMSI risks and drawbacks

The deepest 1-year drawdown on record here is 35.3%.

Who may consider MMSI — and who may not

It is a weaker fit for investors who need monthly cash flow (MMSI does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on MMSI

• All tickers starting with M

Tagged: Healthcare.

Frequently asked questions